4018 results about "Chemical structure" patented technology

A method of forming an aluminum containing film on a substrate includes providing a precursor having the chemical structure: Al(NR₁R₂)(NR₃R₄)(NR₅R₆); where each of R₁, R₂, R₃, R₄, R₅ and R₆ is independently selected from the group consisting of hydrogen and an alkyl group including at least two carbon atoms. The precursor is utilized to form a film on the substrate including at least one of aluminum oxide, aluminum nitride and aluminum oxy-nitride. Each of the R₁-R₆ groups can be the same or different and can by straight or branched chain alkyls. An exemplary precursor that has is useful in forming aluminum containing films is tris diethylamino aluminum.

Polyhydroxyalkanoates (PHAs) from which pyrogen has been removed are provided for use in numerous biomedical applications. PHAs which have been chemically modified to enhance physical and/or chemical properties, for targeting or to modify biodegradability or clearance by the reticuloendothelial system (RES), are described. Methods for depyrogenating PHA polymers prepared by bacterial fermentation processes are also provided, wherein pyrogens are removed from the polymers without adversely impacting the polymers' inherent chemical structures and physical properties. PHAs with advantageous processing characteristics, including low melting points and/or solubility in non-toxic solvents, are also described. PHAs are provided which are suitable for use in in vivo applications such as in tissue coatings, stents, sutures, tubing, bone and other prostheses, bone or tissue cements, tissue regeneration devices, wound dressings, drug delivery, and for diagnostic and prophylactic uses. Properties which are selected for include degradability, elasticity, inclusion of functional groups or derivatized groups, which can in turn be used to attach targeting agents, and bioadhesion.

The present invention relates to a method of producing a cellulose based paper, the paper itself and the use thereof where the paper exhibits enhanced mechanical properties. The method involves providing a suspension of well dispersed modified cellulose at a low concentration. The properties and the chemical structure of the paper make it suitable for in vivo applications such as implant material.

A cationic fluoric surfactant Gemini and its chemical structure are disclosed. Its advantages are lower critical micell concentration, less consumption, and high dispersity, foam stability, penetrability and wettability.

Fluids viscosified with viscoelastic surfactants (VESs) may have their viscosities reduced (gels broken) by the direct or indirect action of a composition that contains at least one metal ion source and optionally at least one second source. An optional second source may be a chelating agent where at least one reducing agent source may be additionally optionally used. Another optional component with the metal ion source includes a second, different metal ion source. The breaking composition is believed to directly attack the VES itself, possibly by disaggregating or otherwise attacking the micellar structure of the VES-gelled fluid, and/or possibly by changing the chemical structure of the VES to give two or more products.

The invention relates to device making it possible to apply a chromophoric composition to the skin, said device including a chromophoric composition containing at least one chromophoric agent. The chromophoric composition is in the form of a layer of constant thickness bonded to one face of backing, at least prior to being applied to the skin, the chromophoric agent or agents being distributed uniformly in said composition, and the type of the composition being chosen such that light energy from laser radiation is transformed locally into heat and/or the chemical structure(s) of the chromophoric agent(s) is/are modified locally.

The present invention relates to an eudesmane type sesquiterpene derivative 1 beta-hydroxyilicic acid, namely 1 beta-hydroxy-5 alpha H-eudesmane-11 (13)-ethylene-12-acid, its medicineal salt or solvent compound and its medicine composition and medicinal application for preparing medicine capable of curing hepatitis B virus infective disease and resisting hepatitis B virus. Said invention also provides its chemical structure formula.

A system for analyzing a vast amount of data representative of chemical structure and activity information and concisely providing conclusions about structure-to-activity relationships. A computer may adaptively learn new substructure descriptors based on its analysis of the input data. The computer may then apply each substructure descriptor as a filter to establish new groups of molecules that match the descriptor. From each new group of molecules, the computer may in turn generate one or more additional new groups of molecules. A result of the analysis in an exemplary arrangement is a tree structure that reflects pharmacophoric information and efficiently establishes through lineage what effect on activity various chemical substructures are likely to have. The tree structure can then be applied as a multi-domain classifier, to help a chemist classify test compounds into structural subclasses.

The present invention belongs to the field of mnacromolecule, relating to the fluorine-containing polyester of low surface energy and the preparation method of the fluorine-containing polyester. The polyester has the following chemical structure (1): wherein R _f C _{is the straight chain of 2} - 21 C or the branch-chain pseudo-perfluoroalkyl; R₁, R₂ is the alkyl, aryl, or naphthenic base of the C₁-C₈; E is -(CH₂) _m-; formula (3) or formula (4); R' is H or the straight chain or the branch-chain alkyl under C₄; m is an integer between 0 or 10. The polyester preparation method is that dibasic acid or the correspondent diester, dihydric alcohol and perfluoroalkane, which are 0.05 percent to 10 percent of the total material weight, are fused and polymerized under vacuum condition. The polyester preparation method at the pseudo-perfluoroalkyl sealed end is simple, and is of good drainage and oil dredging properties. The present invention can be widely used in antifouling coatings, and is of important development and application value.

Fast-curing modified siloxane compositions comprise; (1) an alkoxy- or silanol-functional silicone intermediate, (2) at least one amine reactive ingredient selected from the group consisting of acetoacetate-functional ingredients, acrylate-functional ingredients, and mixtures thereof, (3) an epoxy-functional ingredient, (4) a curing agent selected from the group consisting of amines, aminosilanes, ketimines, aldimines and mixtures thereof, and (5) water. Other ingredients useful in forming fast-curing modified siloxane compositions of this invention include silanes, organometallic catalysts, solvents, pigments, fillers and modifying agents. The above-identified ingredients are combined and reacted to form a fully cured protective film comprising a cross-linked enamine polysiloxane and/or acrylate polysiloxane chemical structure in a reduced amount of time when compared to conventional epoxy siloxane compositions.

The devices and method are provided for detecting labeled and label-free analytes, such as nucleic acids and proteins, employing conjugated cationic, anionic and neutral polymers. The analytes can be immobilized on a solid support material. The solid support material can be disposed in the pre-fabricated patterns on a substrate. The chemical structures of the polymers employed by the various embodiments of the present invention are described herein.

Organic compounds and organic electroluminescence devices employing the same are provided. The organic compound has a chemical structure represented as follows:

wherein, R¹ and R² are independent and can be aryl, heteroaryl, cycloalkyl, hetero-cycloalkyl, or a cycloaliphatic group, or R¹ and R² link together with the carbon atoms to which they are attached to form a fused aryl, heteroaryl, cycloalkyl, hetero-cycloalkyl, or a cycloaliphatic group, and R3, R4, and R5 are independent and can be H, C_1-8 alkyl, C_1-8 alkoxy, C_1-8 halo-alkyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, or a cycloaliphatic group.

A thin film transistor device includes a semiconductor layer. The semiconductor layer includes a compound comprising a chemical structure represented by:

A polymer blend is prepared by dissolving chitosan and a second polymer in an acidic aqueous solution to form an aqueous polymer blend, dehydrating said aqueous polymer blend, and recovering said polymer blend. The second polymer may be selected from the group consisting of polyether glycols including polyethylene glycols; cellulose esters including cellulose acetate; poloxamers; polysaccharides including dextran and guar; polyvinylpyrrolidones; polyvinyl alcohols; and mixtures or copolymers thereof. These polymer blends swell in an acidic environment and deswell in a more neutral or basic environment. This technology is valuable for the dispensing of biologically active material or drugs into a surrounding environment, especially the environment as is found in the gastrointestinal tract. Since the various polymer blends of the present invention are not covalently or ionically crosslinked, but are physically combined, each polymer in the physical blend maintains its original chemical structure, and therefore, is safe for oral administration.

A inkjet recording medium and ink set including ink containing water, a hydrosoluble organic solvent comprising an amide compound represented by the following Chemical Structure 1, a surface active agent; and a coloring agent, and a recording medium containing a substrate; and a coated layer on at least one side of the substrate, wherein the transfer amount of pure water to the recording medium having the coated layer is 2 ml/m² to 35 ml/m² during a contact time of 100 ms and 3 ml/m² to 40 ml/m² during a contact time of 400 ms when measured by a liquid dynamic absorption tester at 23° C. and 50% RH:

The present invention provides phenol derivatives represented by the following general formula or pharmaceutically acceptable salts thereof, or prodrugs thereof, which exhibit an inhibitory activity in human SGLT and are useful as agents for the prevention or treatment of a disease associated with hyperglycemia such as diabetes, postprandial hyperglycemia, impaired glucose tolerance, diabetic complications, obesity or the like, and pharmaceutical compositions comprising the same, and pharmaceutical uses thereof. In the chemical structure, R¹ and R² represent H, OH, NH₂, etc.; R³and R⁴represent H, OH, a halogen atom, an optionally substituted alkyl group, etc.; ring A represents an aryl group or a heteroaryl group; G represents a group represented by the following general formula (G); E¹ represents H or F; and E² represents H, F, or a methyl group, etc.

This invention provides a nonaqueous electrolyte which is excellent in discharge load properties, as well as in high-temperature storage stability, cycling characteristics, high capacitance, continuous charge properties, storage stability, gas evolution suppression in continuous charging, charge/discharge properties at a high current density, discharge load properties and the like, and a rechargeable battery with a nonaqueous electrolyte. The nonaqueous electrolyte contains a monofluorophosphate and/or a difluorophosphate and further contains a compound having a specific chemical structure orspecific properties.

The invention provides a nano suspension liquid concrete early strength agent and a preparation method thereof. The nano suspension liquid concrete early strength agent is prepared from transition metal element doped nano calcium metasilicate suspension liquid, the suspension liquid is mainly composed of nanometer silicon particles, the chemical structure of the nanometer silicon particles is aCaO.bAl2O3.cZnO.SiO2.6H2O, 1<=a<=2, 0.50<=b<=1, and 0.25<=c<=0.50. The nanometer silicon particles are prepared from soluble calcium salt, soluble silicate, soluble aluminum salt, soluble zinc salt and a high polymer dispersing agent. On the one hand, the early strength agent contains no chlorine salt and has no corroding function on steel bars in concrete; on the other hand, an extremely stable suspension liquid system is achieved, adding is facilitated, and the early strength agent can be evenly dispersed easily in the concrete preparation process. The early strength of concrete can be remarkably improved, the early strength effect on concrete adopting highly-doped mineral admixtures is especially obvious, the early strength agent is especially suitable for production of precast concrete components, and a steam maintenance process can be effectively reduced and even omitted.